(Q37189322)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548091%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548091%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

juvenile myelomonocytic leukemia

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548091%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

P D Emanuel

series ordinal

1

1 reference

18 August 2017

publication date

12 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548091%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548091%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548091%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548091%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

1335-1342

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548091%20AND%20SRC:MED&resulttype=core&format=json

Proposals for the classification of the myelodysplastic syndromes

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

The history of myeloproliferative disorders: before and after Dameshek

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Problems in the classification of CMML--dysplastic versus proliferative type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Myelodysplasia and myeloproliferative disorders in childhood: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Central role of tumour necrosis factor, GM‐CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Hyperactive Ras in developmental disorders and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Inherited predispositions and hyperactive Ras in myeloid leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Occurrence of myeloproliferative disorder in patients with Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Juvenile myelomonocytic leukemia and Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Nf1 and Gmcsf interact in myeloid leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Targeting RAS signaling pathways in juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Germline KRAS mutations cause Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Germline gain-of-function mutations in SOS1 cause Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Human herpesvirus 6 infection mimicking juvenile myelomonocytic leukemia in an infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Viral infections in juvenile myelomonocytic leukemia: prevalence and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Hypertelorism With Turner Phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Hematologic effects of inactivating the Ras processing enzyme Rce1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Little response to zoledronic acid in a child of juvenile myelomonocytic leukemia (JMML) harboring the PTPN11 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

A Pilot Study of Isotretinoin in the Treatment of Juvenile Chronic Myelogenous Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

Chronic myelomonocytic leukemia in the light of the WHO proposals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Juvenile monosomy 7 syndrome: evidence that the disease originates in a pluripotent hemopoietic stem cell

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Risk assessment in chronic myelomonocytic leukemia (CMML).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Evidence for the embryonic origin of partial chromosome 7 deletion in monozygotic twins with juvenile chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Haemoglobin and red cell enzyme changes in juvenile myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Spontaneous granulocyte-macrophage colony growth by peripheral blood mononuclear cells in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Prevalence of priapism in children and adolescents with sickle cell anemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

RAS pathway mutations in juvenile myelomonocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

https://api.crossref.org/works/10.1038%2FLEU.2008.162

1 reference

7 January 2021

Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Juvenile chronic myelogenous leukemia: differentiation from infantile cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.162

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18548091%20AND%20SRC:MED&resulttype=core&format=json

release_vrw5rxsn2rdpvamtazeq7qsrv4

8 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vrw5rxsn2rdpvamtazeq7qsrv4

24 November 2022

mapped directly with Wikidata item

1 reference